Abstract
Purpose. The purpose of this study was (i) to validate differentially tape-stripped, porcine skin as an in vitro model for the evaluation of transdermal drug delivery (TDD) to premature neonates, (ii) to determine whether the model could estimate neonatal skin permeability as a function of postconceptional age (PCA), and (iii) to demonstrate that iontophoretic delivery permits precise control of drug input independent of skin barrier function.
Methods. Passive permeation of caffeine, phenobarbital, and lidocaine across tape-stripped porcine skin barriers was measured. Iontophoretic delivery of lidocaine across skins with different barrier competencies was also evaluated.
Results. For all drugs, passive permeation correlated with skin barrier function; that is, with transepidermal water loss (TEWL): Jss = A ⋅ exp[B ⋅ TEWL]. Combining this result with a previously derived dependence of TEWL upon the PCA of premature neonates in vivo allowed a relative value of Jss to be predicted for a given PCA. Comparison of these predictions showed excellent agreement with experimental data reported for diamorphine. Iontophoretic lidocaine delivery was precisely controllable independent of barrier competency.
Conclusions. Porcine skin, in vitro, differentially tape-stripped to specific barrier competencies, is a useful model to explore TDD in premature neonates. The potential for iontophoresis to provide improved dose control and adjustment, irrespective of skin barrier maturity, is established.
Similar content being viewed by others
REFERENCES
N. Rutter. The immature skin. Eur. J. Pediatr. 155:S18–S20 (1996).
Y. N. Kalia, L. B. Nonato, C. H. Lund, and R. H. Guy. Development of skin barrier function in premature infants. J. Invest. Dermatol. 111:320–326 (1998).
M. L. Williams and V. T. Le K. The permeability barrier in the preterm infant. Eur. J. Pediatr. Dermatol. 8:101–106 (1998).
D. A. Barrett and N. Rutter. Transdermal delivery and the premature neonate. Crit. Rev. Ther. Drug Carrier Syst. 11:1–30 (1994).
N. J. Evans and N. Rutter. Transdermal drug delivery to the newborn infant. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery, Marcel Dekker, New York, 1989, pp. 155–176.
J. B. Besunder, M. D. Reed, and J. L. Blumer. Principles of drug biodisposition in the neonate: a critical evalutation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin. Pharmacokinet. 14:189–216 (1988).
N. Barker, J. Hadgraft, and N. Rutter. Skin permeability in the newborn. J. Invest. Dermatol. 88:409–411 (1987).
N. J. Evans, N. Rutter, J. Hadgraft, and G. Parr. Percutaneous administration of theophylline in the preterm infant. J. Pediatr. 107:307–311 (1985).
R. G. Cartwright, P. H. Cartlidge, N. Rutter, C. D. Melia, and S. S. Davis. Transdermal delivery of theophylline to premature infants using a hydrogel disc system. Br. J. Clin. Pharmacol. 29: 553–559 (1990).
M. Amato, M. Isenschmid, and P. Huppi. Percutaneous caffeine application in the treatment of neonatal apnoea. Eur. J. Pediatr. 150:592–594 (1991).
N. J. Evans and N. Rutter. Development of the epidermis in the newborn. Biol. Neonate 49:74–80 (1986).
L. B. Nonato. Evolution of Skin Barrier in Premature Neonates,Ph.D Thesis, University of California, Berkeley, 1997.
N. Sekkat and R. H. Guy. Biological models to study skin permeation. In B.Testa, H. Van de Waterbeemd, G. Folkers, R.H. Guy (eds.), Pharmacokinetic Optimization in Drug Research, Wiley-VCH and VHCA, Zürich, 2001, pp. 155–172.
N. Sekkat, Y. N. Kalia, and R. H. Guy. Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss. J. Pharm. Sci. (2003).
F. P. Bonina, L. Montenegro, G. Micali, D. P. West, P. Palicharla, and R. L. Koch. In vitro percutaneous absorption evaluation of phenobarbital through hairless mouse, adult and premature human skin. Int. J. Pharm. 98:93–99 (1993).
P. G. Green, M. Flanagan, B. Shroot, and R. H. Guy. Iontophoretic drug delivery. In K.A. WaltersJ. Hadgraft (eds.), Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, 1993, pp. 311–333.
P. M. Lai and M. S. Roberts. Iontophoresis. In M.S. Roberts and K. A. Walters (eds.), Dermal Absorption and Toxicity Assessment, Marcel Dekker, New York, 1998, pp. 371–414.
O. Wong. Iontophoresis: fundamentals. In D.S. Hsieh (ed), Drug Permeation Enhancement, Theory and Applications, Marcel Dekker, New York, 1994, pp. 219–246.
N. Kanikkannan, J. Singh, and P. Ramarao. In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species. J. Control. Rel. 71:99–105 (2001).
D. A. Barrett and N. Rutter. Percutaneous lignocaine absorption in newborn infants. Arch. Dis. Child. 71:F122–F124 (1994).
P. Glikfeld, C. Cullander, R. S. Hinz, and R. H. Guy. A new system for in vitro studies of iontophoresis. Pharm. Res. 5:443–446 (1988).
A. Naik. Azidoprofen as a Soft Anti-Inflammatory Agent for the Sekkat, Kalia, and Guy 1396 Topical Treatment of Psoriasis.Ph.D Thesis, University of Aston, Birmingham, 1990.
G. K. Herkes, 496:147–154 (1989).
D. R. Friend. In vitro skin permeation techniques. J. Control. Rel. 18:235–248 (1992).
W. R. Ravis. Data interpretation and analysis in percutaneous absorption studies. In B.W. Kemppainen and W. G. Reifenrath (eds.), Methods for Skin Absorption, CRC Press, Boca Raton, 1990, pp. 147–163.
D. A. Barrett, N. Rutter, and S. S. Davis. An in vitro study of diamorphine permeation through premature human neonatal skin. Pharm. Res. 10:583–587 (1993).
D. A. Barrett and N. Rutter. Percutaneous lignocaine absorption in newborn infants. Arch. Dis. Child. 71:F122–F124 (1994).
K. C. Sung, J. Y. Fang, and O. Y. Hu. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. J. Control. Rel. 67:1–8 (2000).
D. Marro, Y. N. Kalia, M. B. Delgado-Charro, and R. H. Guy. Contribution of electromigration and electro-osmosis to iontophoretic drug delivery: I. Lidocaine hydrochloride. Pharm. Res. 18:1707–1713 (2001).
D. Marro, R. H. Guy, and M. B. Delgado-Charro. Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Controlled Release 70:213–217 (2001).
Y. N. Kalia, L. B. Nonato, C. H. Lund, and R. H. Guy. Development of skin barrier function in premature infants. J. Invest. Dermatol. 111:320–326 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sekkat, N., Kalia, Y.N. & Guy, R.H. Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates. Pharm Res 21, 1390–1397 (2004). https://doi.org/10.1023/B:PHAM.0000036912.94452.d0
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000036912.94452.d0